Partners
Proud to Partner with:
Biose Industrie
Lead Partner
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products (LBPs) and Next Generation Probiotics (NGPs). Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for over 70 years. With 52000m² GMP Microbiome centre of excellence in France and our Tech transfer laboratory close to Boston we offer:
- Process and Analytical Development for Drug Substance and Drug Product
- Scale up for Drug Substance and Drug product
- GMP manufacturing for clinical and commercial Drug Substance and Drug Product including Placebo and full packaging and labelling
- We have experience with over 400 different strains of bacteria and 70% of them are strictly anaerobic micro-organisms.
Bac3Gel
Expertise Partner
Who We Are:
Bac3Gel is an innovation company that unblocks the full power of microbiota by providing the complexity of native ecosystems in a simple way.
What We Do:
Ready to use in vitro models and Growth enhancer Beads.
Our technology is a tailorable system that provides the microbiota with the required conditions to thrive.
Available Standard Formulations for different districts:
Oral, Airway, Gastric, Intestinal, Cervicovaginal, and Universal.
Wacker Biotech
Expertise Partner
Wacker Biotech is the CDMO partner of choice for process development and contract manufacturing of biopharmaceuticals (live biotherapeutic products, proteins, vaccines, plasmid DNA and mRNA). With our proprietary LIBATEC® platform, we offer clients vast experience in process development, optimization, analytical testing and GMP manufacturing of live biotherapeutic products (LBPs). LIBATEC® provides a monoseptic environment suitable for a wide range of LBPs from diverse bacterial strains, and for both aerobic and nonaerobic fermentation regimes.
Cosmos ID
Exhibition Partner
We offer end-to-end solutions for microbiome science from discovery through clinical validation. Untangle the complexity of the microbiome with CLIA-certified & ICH-GCP compliant NGS and metabolomics services and bioinformatics solutions. Results can be accessed via the CosmosID-HUB, a user-friendly and interactive software for microbiome analysis, or through customized reporting. Unravel complexities of microbial communities and decode genetic and metabolic fingerprints with advanced bioinformatic pipelines that enable clonal-level resolution, engraftment persistence analysis correlated to clinical outcomes and in silico screens that de-risk strain selection and reduce development time. Our expertise in integrative systems biology and immunology will provide the support you need to understand the microbiome in health and disease.
Want to join these microbiome leaders?
